The relation of ADMA and apelin to endothelial dysfunction and angiogenesis in patients with type 2 diabetes mellitus.
Tasci
Ilker
I
Erdem
Gokhan
G
Tapan
Serkan
S
D000073861:Apelin; D001120:Arginine / Q000031:analogs & derivatives* / Q000097:blood; D003924:Diabetes Mellitus, Type 2 / Q000503:physiopathology*; D003925:Diabetic Angiopathies / Q000097:blood / Q000503:physiopathology; D003930:Diabetic Retinopathy / Q000503:physiopathology; D004730:Endothelium, Vascular / Q000503:physiopathology*; D006801:Humans; D036341:Intercellular Signaling Peptides and Proteins / Q000097:blood*; D008019:Life Style; D009389:Neovascularization, Pathologic / Q000503:physiopathology*
C115436:APLN protein, human; D000073861:Apelin; D036341:Intercellular Signaling Peptides and Proteins; C487735:dimethylarginine; D001120:Arginine